Abstract:Degradable polar hydrophobic ionic polyurethanes (D-PHI) are an emerging class of biomaterials with particular significance for blood-contacting applications due to their immunomodulatory effects and highly customizable block chemistry. In this manuscript, D-PHI polymer was formulated as a nanoparticle excipient for the first time by inverse emulsion polymerization. The nanoparticles were optimized with consideration of diameter, surface charge, size variability, and yield as a delivery vehicle for a custom vascular therapeutic peptide. A layer-by-layer (LBL) surface modification technique using poly-L-lysine was integrated within the nanoparticle design to optimize therapeutic loading efficiency. Solvent pH played a pivotal role in emulsion micelle formation, LBL polymer secondary structure, and the polymer functional group interactions critical for high therapeutic loading. The resulting nanoparticle platform met target size (200 ± 20 nm), polydispersity (<0.07), and storage stability standards, was nontoxic, and did not affect therapeutic peptide bioactivity in vitro. Surface-modified D-PHI nanoparticles can be reproducibly manufactured at low cost, generating a highly customizable excipient platform suitable for delivery of biomolecular therapeutics. These nanoparticles have potential applications in vascular drug delivery via localized infusion, drug eluting stents, and drug-coated angioplasty balloons. STATEMENT OF SIGNIFICANCE: Nanoscale excipients have become critical in the delivery of many therapeutics to enhance drug stability and targeted biodistribution through careful design of nanoparticle composition, surface chemistry, and size. This manuscript describes the development of a nanoparticle excipient derived from an immunomodulatory degradable polar hydrophobic ionic polyurethane, in combination with a layer-by-layer surface modification approach utilizing poly-L-lysine, to transport a mimetic peptide targeting smooth muscle cell migration in vascular disease. The nanoparticle platform draws on the effect of pH to maximize drug loading and tailor particle properties. The low cost and easily reproducible system presents a highly customizable platform that can be adapted for therapeutic delivery across a wide range of clinical indications.

Application Research of a Novel Designed Peptide As a Potential Carrier

Study on the Designed Self-Assembling Peptide As Potential Drug Carrier by Fluorescence Spectra

A Designed Amphiphilic Peptide Containing the Silk Fibroin Motif As a Potential Carrier of Hydrophobic Drugs

Dynamic Research of A Potential Carrier for Hydrophobic Compound Model Pyrene Using Amphiphilic Peptide Eyk

Fluorescence Studies on a Designed Peptide of REIP As a Potential Hydrophobic Drug Carrier

Fluorescence Studies On A Designed Self-Assembling Peptide Of Rad16-Ii As A Potential Carrier For Hydrophobic Drug

The Amphiphilic Self-Assembling Peptide EAK16-I As a Potential Hydrophobic Drug Carrier

Preliminary Research on the Interaction Between a Novel Designed Self-Assembling Peptide with Half-Sequence Ionic Complement and the Natural Product Psoralen

Water-compatible Surface-Imprinted Microspheres for High Adsorption and Selective Recognition of Peptide Drug from Aqueous Media

Synergetically Understanding the Interaction Between Nano/microspheres and Peptide for Controllable Drug Loading Via Experimental and Theoretical Approaches.

Optimisation of a Microfluidic Method for the Delivery of a Small Peptide

A non-spherical nanoparticles system for the delivery of peptides using polymer grafted nanocellulose

Cyclodextrin-Based Peptide Self-Assemblies (spds) That Enhance Peptide-Based Fluorescence Imaging and Antimicrobial Efficacy.

Stable, Bioresponsive, and Macrophage-Evading Polyurethane Micelles Containing an Anionic Tripeptide Chain Extender

Efficient Delivery of Cyclic Peptides into Mammalian Cells with Short Sequence Motifs

A High-Efficiency, Low-Toxicity, Phospholipids-Based Phase Separation Gel for Long-Term Delivery of Peptides.

Design and Evaluation of a PEGylated Lipopeptide Equipped with Drug-Interactive Motifs As an Improved Drug Carrier

Construction of surfactant-like tetra-tail amphiphilic peptide with RGD ligand for encapsulation of porphyrin for photodynamic therapy.

Recent Progress of Cell-Penetrating Peptides As New Carriers for Intracellular Cargo Delivery.

Biomimetic Amphiphiles for Polymeric Micellar Carrier System

Synthesis, characterization, and surface modification of degradable polar hydrophobic ionic polyurethane nanoparticles for the delivery of therapeutics to vascular tissue